1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 197 F.Supp.3d
  5. 197 F.Supp.3d 557 (2016)
 

GILLIS v. QRX PHARMA LTD.

15 Civ. 4868 (PAE).

197 F.Supp.3d 557 (2016)

Marsha GILLIS, Carl Bayney, and Daniel Rehmsmeyer, individually and on behalf of all others similarly situated, Plaintiffs, v. QRX PHARMA LTD. and John Holaday, Defendants.

United States District Court, S.D. New York.

Signed July 6, 2016.

Attorney(s) appearing for the Case

Phillip C. Kim, Jonathan Stern, Laurence Matthew Rosen, The Rosen Law Firm P.A., New York, NY, for Plaintiffs.

Ellen Victoria Holloman, Olshan Frome Wolosky LLP, Stephen Mark Dollar, Norton Rose Fulbright US LLP, New York, NY, Peter Andrew Stokes, Fulbright & Jaworski LLP, Austin, TX, for Defendants.

OPINION & ORDER

In this putative class action under the federal securities laws, lead plaintiffs Marsha Gillis, Carl Bayney, and Daniel Rehmsmeyer (collectively, "plaintiffs") claim that the Australian pharmaceutical company QRX's Pharma Ltd. ("QRX" or the "Company") and its former CEO John Holaday...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases